These findings provide a deeper understanding of the mechanisms by which PRDX5 preserves skeletal muscle integrity and suggest that enhancing the expression or activity of PRDX5 and PRDX3 could serve as a promising therapeutic strategy to counteract sarcopenia and age‐associated muscle degeneration. The gene discussed is PRDX3; the disease is Skeletal muscle atrophy.